Association of CTLA-4 and IL-4 polymorphisms in viral induced liver cancer
Authors:
- Maria ShabbirMSMaria Shabbir
- Yasmin BadshahYBYasmin Badshah
- Khushbukhat KhanKKKhushbukhat Khan
- Janeen H. TrembleyJaneen H. Trembley
- Areeb RizwanARAreeb Rizwan
- Fatima FarazFFFatima Faraz
- Syeda Alveena ShahSSSyeda Alveena Shah
- Mahrukh FarooqiMFMahrukh Farooqi
- Naeem Mahmood AshrafNANaeem Mahmood Ashraf
- Tayyaba AfsarTATayyaba Afsar
- Ali AlmajwalAAAli Almajwal
- Nawaf W. AlruwailiNANawaf W. Alruwaili
Open Access
- 7 May 2022
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-9
Abstract
Background: Hepatocellular carcinoma (HCC) is one of the most prevalent types of cancer and is responsible for close to one million annual deaths globally. In Pakistan, HCC accounts for 10.7% of cancer incidence. Prior studies indicated an association between interleukin 4 (IL-4) and cytotoxic T lymphocyte protein 4 (CTLA-4) gene polymorphisms in many types of cancers, including HCC that are either hepatitis B virus (HBV)- or hepatitis C Virus (HCV)-induced. The association of IL-4 and CTLA-4 genetic polymorphisms with HCV-induced HCC is not yet determined in the Pakistani population. Therefore, this research is designed to investigate the implication of IL-4 and CTLA-4 gene polymorphisms by determining the association of IL-4 -590 C/T (rs2243250) and CTLA-4 + 49 A/G (rs231775) with HCC in Pakistan. Methods: Different bioinformatics tools were employed to determine the pathogenicity of these polymorphisms. Samples were collected from HCV-induced HCC patients, followed by DNA extraction and ARMS-PCR analysis. Results: The SNP analysis results indicated a positive association of IL-4 -590C/T and CTLA-4 + 49A/G gene polymorphisms with HCV-induced HCC in Pakistan. The CTLA-4 polymorphism might enhance therapeutic efficiency of HCC chemotherapy medicines. The IL-4 polymorphism might introduce new transcription factor binding site in IL-4 promoter region. Conclusion: This study delineated risk factor alleles in CTLA-4 and IL-4 genes associated with HCV-mediated HCC among Pakistani patients that may have application to serve as genetic markers for pre- and early diagnosis and prognosis of HCC in HCV patients.Keywords
This publication has 47 references indexed in Scilit:
- Adding an unnatural covalent bond to proteins through proximity-enhanced bioreactivityNature Methods, 2013
- VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trialsThe Lancet Oncology, 2012
- Sample size estimation and power analysis for clinical research studiesJournal of Human Reproductive Sciences, 2012
- LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug DiscoveryJournal of Chemical Information and Modeling, 2011
- CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers—hepatocellular carcinoma and cervical cancerHuman Immunology, 2010
- Hepatocellular carcinoma: a global viewNature Reviews Gastroenterology & Hepatology, 2010
- Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer riskCarcinogenesis, 2010
- +49G > A polymorphism in the cytotoxic T-lymphocyte antigen-4 gene increases susceptibility to hepatitis B-related hepatocellular carcinoma in a male Chinese populationHuman Immunology, 2010
- Liver Cancer2006
- Association of the CTLA-4 Gene 49 A/G Polymorphism With Type 1 Diabetes and Autoimmune Thyroid Disease in Japanese ChildrenDiabetes Care, 2003